According to a report from the Association of the British Pharmaceutical Industry (ABPI), the UK is taking longer to recover from the COVID-19 pandemic than its European peers. More: ABPI: UK’s clinical research enduring slow recovery Source: News
read moreViiV Healthcare, global specialist HIV company owned by GlaxoSmithKline (GSK), has announced an exclusive collaboration with Shionogi & Co Ltd (Shionogi) to develop a third-generation HIV integrase inhibitor (INSTI), with potential for ultra-long-acting dosing intervals. More: GSK’s ViiV Healthcare agrees
read moreIn Humira kickbacks case, disgruntled AbbVie investors score class-action status kdunleavy Tue, 09/28/2021 – 13:43 More: In Humira kickbacks case, disgruntled AbbVie investors score class-action status Source: fierce
read moreAmid new pricing pressure, Lilly cuts cost of generic insulin by another 40% kdunleavy Tue, 09/28/2021 – 09:53 More: Amid new pricing pressure, Lilly cuts cost of generic insulin by another 40% Source: fierce
read moreMerck’s reported $11B Acceleron buy could help it diversify beyond Keytruda, but antitrust hurdles loom: analysts aliu Tue, 09/28/2021 – 09:50 More: Merck's reported B Acceleron buy could help it diversify beyond Keytruda, but antitrust hurdles loom: analysts Source: fierce
read moreAlmac proposes expansion of its Northern Ireland production facility: report jkeenan Tue, 09/28/2021 – 09:24 More: Almac proposes expansion of its Northern Ireland production facility: report Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals